A Study to Identify a Biomarker Predictive for Response on Everolimus in Solid Tumors (CPCT-03)

Clinical trial NCT01566279 · COMPLETED

Trial details

NCT number: NCT01566279
Sponsor: UMC Utrecht
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2012-08-01
Primary completion: 2015-11-01
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.